SentiSense
Ctrl+K
Quick tip: Press
to search stocks
L
LLY
Eli Lilly and Company
$990.33
+7.07 (+0.72%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$990.33
Live market price
P/E (TTM)
43.15
EPS: $22.95
P/S (TTM)
13.57
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 10:23:53 PM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
6.4M
% of Float
0.8%
Days to Cover
1.4
Avg Daily Vol
4.4M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
1.91
Leverage ratio
ROE (TTM)
77.78%
Return on equity
Income Statement
Revenue
$65.18B
Cost of Revenue
$11.05B
Gross Profit
$54.13B
Operating Income
$25.73B
Net Income
$20.64B
EPS (Quarter)
$22.95
EPS (TTM)
--
Balance Sheet
Total Assets
$112.48B
Total Liabilities
$85.94B
Shareholders' Equity
$26.54B
Current Assets
$55.63B
Current Liabilities
$35.23B
Cash & Equivalents
--
Long-Term Debt
--
Cash Flow
Operating Cash Flow
$16.81B
Investing Cash Flow
$-10.97B
Financing Cash Flow
$-2.21B
Free Cash Flow
$5.84B
Profitability Margins
Gross Margin
83.04%
Operating Margin
39.48%
Net Profit Margin
31.67%
ROA (TTM)
18.35%
ROE (TTM)
77.78%
Data source: Polygon.io
Last updated: 3/8/2026, 10:23:54 PM
Company Profile
Symbol
LLY
Market Cap
$884.36B
IPO Date
Jul 9, 1970
CEO
--
Employees
50,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Read MoreSimilar Stocks
AMGN
Amgen Inc.
$369.53
+0.53%
VRTX
Vertex Pharmaceuticals Incorporated
$456.69
-0.90%